KEGG   DISEASE: CD36 deficiency
Entry
H01108                      Disease                                
Name
CD36 deficiency;
Platelet glycoprotein IV deficiency;
Bleeding disorder platelet-type 10 (BDPLT10)
  Supergrp
Bleeding disorder platelet-type [DS:H01235]
Description
Human genetic platelet glycoprotein IV (CD36) deficiency may be related to the phenotypic expression of the metabolic syndrome and is frequently associated with atherosclerotic cardiovascular diseases. CD36 deficiency is relatively frequent in Asian and African populations. It also has been reported that CD36 deficiency might be linked with cardiomyopathy. This deficiency can be classified in two subgroups: the type I phenotype is characterized by platelets and monocytes/macrophages that exhibit CD36 deficiency; whereas in the type II phenotype, the surface expression of CD36 is lacking only in platelets, but expression is near normal in monocytes/macrophages.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Disorders of lipoprotein metabolism or certain specified lipidaemias
    5C80  Hyperlipoproteinaemia
     H01108  CD36 deficiency
Pathway-based classification of diseases [BR:br08402]
 Cellular process
  nt06535  Efferocytosis
   H01108  CD36 deficiency
Pathway
hsa04148  Efferocytosis
hsa04920  Adipocytokine signaling pathway
hsa04975  Fat digestion and absorption
hsa04979  Cholesterol metabolism
hsa04931  Insulin resistance
Network
nt06535 Efferocytosis
Gene
CD36 [HSA:948] [KO:K06259]
Other DBs
ICD-11: 5C80.Y
MeSH: C564245
OMIM: 608404
Reference
  Authors
Hirano K, Kuwasako T, Nakagawa-Toyama Y, Janabi M, Yamashita S, Matsuzawa Y
  Title
Pathophysiology of human genetic CD36 deficiency.
  Journal
Trends Cardiovasc Med 13:136-41 (2003)
DOI:10.1016/S1050-1738(03)00026-4
Reference
  Authors
Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, Poliakov E, Sun M, Finton PJ, Curtis BR, Chen J, Zhang R, Silverstein RL, Hazen SL
  Title
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype.
  Journal
Nat Med 13:1086-95 (2007)
DOI:10.1038/nm1626
LinkDB

» Japanese version

KEGG   DISEASE: Coronary artery disease
Entry
H01742                      Disease                                
Name
Coronary artery disease
  Subgroup
Autosomal dominant coronary artery disease (ADCAD)
Coronary heart disease (CHD)
Description
Coronary artery disease (CAD) is one of the leading causes of death globally. CAD is coupled to a pathogenic process in which lipids and lipoproteins accumulate in the subendothelial intimal layer of the vessel wall. A variety of environmental and genetic risk factors are associated with CAD, including hypercholesterolemia, hypertension, obesity, diabetes, and a family history of early CAD. It has been reported that an autosomal dominant form of CAD is caused by the mutation in transcription factor MEF2A. A missense mutation in LRP6, which encodes a co-receptor in the Wnt signaling pathway, has also been identified.
Category
Cardiovascular disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 11 Diseases of the circulatory system
  Diseases of coronary artery
   BA8Z  Diseases of coronary artery, unspecified
    H01742  Coronary artery disease
Pathway-based classification of diseases [BR:br08402]
 Cellular process
  nt06535  Efferocytosis
   H01742  Coronary artery disease
Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
hsa04148  Efferocytosis
Network
nt06535 Efferocytosis
Gene
(ADCAD1) MEF2A [HSA:4205] [KO:K09260]
(ADCAD2) LRP6 [HSA:4040] [KO:K03068]
(CHDS1) CX3CR1 [HSA:1524] [KO:K04192]
(CHDS5) KALRN [HSA:8997] [KO:K15048]
(CHDS6) MMP3 [HSA:4314] [KO:K01394]
(CHDS7) CD36 [HSA:948] [KO:K06259]
Drug
Nitroglycerin [DR:D00515]
Niacin [DR:D00049]
Amlodipine benzoate [DR:D11881]
Perindopril erbumine [DR:D00624]
Amlodipine besilate and atorvastatin calcium [DR:D08488]
Other DBs
ICD-11: BA8Z
ICD-10: I25.1
MeSH: D003324
OMIM: 608320 610947 607339 608901 614466 610938
Reference
  Authors
Olson EN
  Title
Coronary artery disease and the MEF2A transcription factor.
  Journal
Sci Aging Knowledge Environ 2003:pe33 (2003)
DOI:10.1126/sageke.2003.48.pe33
Reference
  Authors
Grover MP, Ballouz S, Mohanasundaram KA, George RA, Goscinski A, Crowley TM, Sherman CD, Wouters MA
  Title
Novel therapeutics for coronary artery disease from genome-wide association study data.
  Journal
BMC Med Genomics 8 Suppl 2:S1 (2015)
DOI:10.1186/1755-8794-8-S2-S1
Reference
PMID:14645853 (MEF2A)
  Authors
Wang L, Fan C, Topol SE, Topol EJ, Wang Q
  Title
Mutation of MEF2A in an inherited disorder with features of coronary artery disease.
  Journal
Science 302:1578-81 (2003)
DOI:10.1126/science.1088477
Reference
PMID:17332414 (LRP6)
  Authors
Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP
  Title
LRP6 mutation in a family with early coronary disease and metabolic risk factors.
  Journal
Science 315:1278-82 (2007)
DOI:10.1126/science.1136370
Reference
PMID:11264153 (CX3CR1)
  Authors
Moatti D, Faure S, Fumeron F, Amara Mel-W, Seknadji P, McDermott DH, Debre P, Aumont MC, Murphy PM, de Prost D, Combadiere C
  Title
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
  Journal
Blood 97:1925-8 (2001)
DOI:10.1182/blood.v97.7.1925
Reference
PMID:17357071 (KALRN)
  Authors
Wang L, Hauser ER, Shah SH, Pericak-Vance MA, Haynes C, Crosslin D, Harris M, Nelson S, Hale AB, Granger CB, Haines JL, Jones CJ, Crossman D, Seo D, Gregory SG, Kraus WE, Goldschmidt-Clermont PJ, Vance JM
  Title
Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease.
  Journal
Am J Hum Genet 80:650-63 (2007)
DOI:10.1086/512981
Reference
PMID:8662692 (MMP3)
  Authors
Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM
  Title
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.
  Journal
J Biol Chem 271:13055-60 (1996)
DOI:10.1074/jbc.271.22.13055
Reference
PMID:15282206 (CD36)
  Authors
Ma X, Bacci S, Mlynarski W, Gottardo L, Soccio T, Menzaghi C, Iori E, Lager RA, Shroff AR, Gervino EV, Nesto RW, Johnstone MT, Abumrad NA, Avogaro A, Trischitta V, Doria A
  Title
A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians.
  Journal
Hum Mol Genet 13:2197-205 (2004)
DOI:10.1093/hmg/ddh233
LinkDB

» Japanese version

DBGET integrated database retrieval system